Nexium, Esomeprazole News

Researchers in the latest American Journal of Gastroenterology find that eradicating Helicobacter pylori infection is necessary in patients using long-term esomeprazole for reflux esophagitis.

To the Editor: In their article on the use of esomeprazole in patients with poorly controlled asthma ,1 Mastronarde et al.

PUMP INHIBITORS that are used to treat acid reflux have been associated with an increased risk for pneumonia, according to a recent study.

Popular antacids known as proton pump inhibitors , or PPIs , may cause or aggravate the very acid-reflux symptoms they're used to treat, according to a new study.

After proton pump inhibitor therapy is withdrawn, patients may be likely to experience acid-related symptoms, according to a study published in the July issue of Gastroenterology .

Jun 30, 2009 - POZEN Inc. , today announced the submission of a New Drug Application to the U.S. Food and Drug Administration for the marketing approval of VIMOVO , the combination of enteric coated naproxen and immediate release esomeprazole.

New Study Shows Nexium 40 Mg And 20 Mg Reduced Gastric And Duodenal Ulcers By 80 - 85% In Patients Taking Low-Dose Aspirin For CV Protection Esomeprazole significantly reduced the occurrence of gastric and duodenal ulcers and upper gastrointestinal symptoms in patients taking low-dose aspirin for risk reduction of adverse cardiovascular events[i], ...

Two studies from AstraZeneca show that symptomatic gastroesophageal reflux disease patients treated with NEXIUM 20 mg daily experienced greater relief from nighttime heartburn and GERD-related sleep disturbances compared with patients taking placebo over four weeks .

Heartburn is ailing the masses. By one estimate, 20 percent of the Western population experiences acid reflux at least once a week.

It's not until you read the Indian press that it dawns on you what a total disaster Ranbaxy is - and by extension its deal to supply AstraZeneca with a Nexium ingredient.

Minakem Group, through its holding company Minafin, has completed the acquisition of a multi-purpose APIs plant, formerly owned by AstraZeneca and has signed with the latter a long-term supply contract for Budesonide, Omeprazole and Esomeprazole.

A new study has added to the concern that commonly used proton-pump inhibitors may interfere with Plavix in people who have coronary artery disease.

WILMINGTON,A Del. Anglo-Swedish drug maker AstraZeneca announced Monday that it had submitted an approval application to the Food and Drug Administration for a low-dose medication designed to reduce the risk of gastric and duodenal ulcers associated with low-dose aspirin.

Four of the most commonly prescribed heartburn medications reduce the benefit associated with clopidogrel, a widely used antiplatelet medication also known by its brand name, Plavix.

The anti-clotting action of the medication clopidogrel can be compromised by common drugs for the treatment of heartburn and ulcers resulting in a roughly 50% increase in the combined risk of hospitalization for heart attack, stroke and other serious cardiovascular illnesses, according to a new study presented today at the Society for ...

Main Category: GastroIntestinal / Gastroenterology Also Included In: Regulatory Affairs / Drug Approvals Article Date: 05 May 2009 - 8:00 PDT AstraZeneca announced today that it has completed the Mutual Recognition Procedure in Europe with Sweden as Reference Member State for the use of Nexium to prevent peptic ulcer re-bleeding in adults.1 Nexium ...

AstraZeneca has announced the submission of a new drug application to the U.S. Food and Drug Administration seeking approval for a product combining low dose aspirin with esomeprazole magnesium for the risk reduction of low dose aspirin-associated gastric and/or duodenal ulcers in patients at risk.

This week's New England Journal of Medicine examines the efficacy of esomeprazole for treatment of poorly controlled asthma.

A commonly used treatment for acid reflux does not improve asthma symptoms or control in patients who do not have symptoms of gastroesophageal reflux , according to a new study supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health and by the American Lung Association .

New research suggests that a widely used treatment for persistent acid reflux among asthmatics doesna t actually improve their quality of life.